Why Are There So Few FDA-Approved Therapeutics for Wound Healing?

Why Are There So Few FDA-Approved Therapeutics for Wound Healing?

Since the only and the milestone FDA approval of becaplermin gel (Regranex<sup>TM</sup>, 0.01% human recombinant PDGF-BB) as a (diabetic) wound healing therapeutic more than 25 years ago, no new therapeutic (excluding physical therapies, devices, dressings, anti-microbial agents, or othe...

Full description

Bibliographic Details
Main Authors: Mei Chen, Cheng Chang, Brandon Levian, David T. Woodley, Wei Li
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:International Journal of Molecular Sciences
Subjects:
wound healing
therapeutics
builder vs damager
Online Access:https://www.mdpi.com/1422-0067/24/20/15109

Similar Items

Similar Items